{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:38:41Z","timestamp":1792809521190,"version":"4.5.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Roche Egypt"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Public Health"],"DOI":"10.1186\/s13690-026-02122-8","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:06:34Z","timestamp":1792757194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advancing women\u2019s health in Egypt: an economic evaluation of the presidential initiative for nationwide breast cancer early detection and treatment"],"prefix":"10.1186","volume":"84","author":[{"given":"Khaled","family":"Abdelghaffar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Hassany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham","family":"Elghazaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Morsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"Shash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed H","family":"Abdelaziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loay","family":"Kassem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nany","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia","family":"Shaltout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma Mohamed","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Abo Bakr","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana Elsayed","family":"Bendary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howaida","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salwa","family":"Gazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassant","family":"Atef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0697-6464","authenticated-orcid":false,"given":"Islam","family":"Anan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"issue":"3","key":"2122_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"2122_CR2","doi-asserted-by":"publisher","unstructured":"Batran RA, Tahoun S, Helmy L, Bahr A, Khalil A, Kamel M, et al. Breast Cancer in the Middle East and North Africa: Economic Burden, Market Trends, and Care Challenges. JCO Oncol Pract. 2025;OP2500354. https:\/\/doi.org\/10.1200\/OP-25-00354.","DOI":"10.1200\/OP-25-00354"},{"issue":"20","key":"2122_CR3","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.2174\/1381612827666210303141416","volume":"27","author":"F Noor","year":"2021","unstructured":"Noor F, Noor A, Ishaq AR, Farzeen I, Saleem MH, Ghaffar K, et al. Recent Advances in Diagnostic and Therapeutic Approaches for Breast Cancer: A Comprehensive Review. Curr Pharm Des. 2021;27(20):2344\u201365. https:\/\/doi.org\/10.2174\/1381612827666210303141416.","journal-title":"Curr Pharm Des"},{"issue":"S3","key":"2122_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.7314\/apjcp.2016.17.s3.43","volume":"17","author":"M Ghoncheh","year":"2016","unstructured":"Ghoncheh M, Pournamdar Z, Salehiniya H. Incidence and Mortality and Epidemiology of Breast Cancer in the World. Asian Pac J Cancer Prev. 2016;17(S3):43\u20136. https:\/\/doi.org\/10.7314\/apjcp.2016.17.s3.43.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"7","key":"2122_CR5","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1007\/s12325-024-02893-y","volume":"41","author":"M Franklin","year":"2024","unstructured":"Franklin M, Pollard D, Sah J, Rayner A, Sun Y, Dube F, et al. Direct and Indirect Costs of Breast Cancer and Associated Implications: A Systematic Review. Adv Ther. 2024;41(7):2700\u201322. https:\/\/doi.org\/10.1007\/s12325-024-02893-y.","journal-title":"Adv Ther"},{"issue":"4","key":"2122_CR6","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1001\/jamaoncol.2022.7826","volume":"9","author":"S Chen","year":"2023","unstructured":"Chen S, Cao Z, Prettner K, Kuhn M, Yang J, Jiao L, et al. Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050. JAMA Oncol. 2023;9(4):465\u201372. https:\/\/doi.org\/10.1001\/jamaoncol.2022.7826.","journal-title":"JAMA Oncol"},{"issue":"1","key":"2122_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13045-025-01660-y","volume":"18","author":"T Li","year":"2025","unstructured":"Li T, Zhang H, Lian M, He Q, Lv M, Zhai L, et al. Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021. J Hematol Oncol. 2025;18(1):5. https:\/\/doi.org\/10.1186\/s13045-025-01660-y.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"2122_CR8","doi-asserted-by":"publisher","first-page":"13092","DOI":"10.1038\/s41598-025-97482-6","volume":"15","author":"C Li","year":"2025","unstructured":"Li C, Ke P. Regional differences in the disease burden and attributable risk factors of female cancers. Sci Rep. 2025;15(1):13092. https:\/\/doi.org\/10.1038\/s41598-025-97482-6.","journal-title":"Sci Rep"},{"key":"2122_CR9","doi-asserted-by":"publisher","first-page":"437971","DOI":"10.1155\/2014\/437971","volume":"2014","author":"AS Ibrahim","year":"2014","unstructured":"Ibrahim AS, Khaled HM, Mikhail NN, Baraka H, Kamel H. Cancer incidence in egypt: results of the national population-based cancer registry program. J Cancer Epidemiol. 2014;2014:437971. https:\/\/doi.org\/10.1155\/2014\/437971.","journal-title":"J Cancer Epidemiol"},{"key":"2122_CR10","unstructured":"Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Pi\u00f1eros M, Znaor A, Soerjomataram I, Bray F. Global Cancer Observatory: Cancer Today (version 1.1). Egypt, GLOBOCAN 2022 fact sheet. Lyon, France: International Agency for Research on Cancer; 2024. Available from. https:\/\/gco.iarc.who.int\/today."},{"key":"2122_CR11","unstructured":"Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Pi\u00f1eros M, Znaor A, Soerjomataram I, Bray F. Global Cancer Observatory: Cancer Today (version 1.1). United States of America, GLOBOCAN 2022 fact sheet. Lyon, France: International Agency for Research on Cancer; 2024. Available from: International Agency for Research on Cancer. United States of America. GLOBOCAN 2022. Report No. 2022;840. https:\/\/gco.iarc.who.int\/today."},{"key":"2122_CR12","doi-asserted-by":"publisher","first-page":"e2200387","DOI":"10.1200\/GO.22.00387","volume":"9","author":"HA Azim","year":"2023","unstructured":"Azim HA, Elghazawy H, Ghazy RM, Abdelaziz AH, Abdelsalam M, Elzorkany A, et al. Clinicopathologic Features of Breast Cancer in Egypt-Contemporary Profile and Future Needs: A Systematic Review and Meta-Analysis. JCO Glob Oncol. 2023;9:e2200387. https:\/\/doi.org\/10.1200\/GO.22.00387.","journal-title":"JCO Glob Oncol"},{"key":"2122_CR13","doi-asserted-by":"publisher","unstructured":"Mohammed MA, Mokhtar S, Osama E, Sherif O. Retrospective descriptive analysis of the demographic and clinicopathological presentation of breast cancer patients in Kasr Al-Ainy Hospital over 5 years. Egypt J Surg. 2024;43(2). https:\/\/doi.org\/10.4103\/ejs.ejs_316_23.","DOI":"10.4103\/ejs.ejs_316_23"},{"key":"2122_CR14","unstructured":"National Cancer Institute. Cancer Stat Facts: Female Breast Cancer. Bethesda, MD: National Cancer Institute. 2026 [Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/breast.html ]."},{"key":"2122_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.breast.2021.12.006","volume":"61","author":"HJ Kim","year":"2022","unstructured":"Kim HJ, Kim S, Freedman RA, Partridge AH. The impact of young age at diagnosis (age\u2009<\u200940 years) on prognosis varies by breast cancer subtype: A U.S. SEER database analysis. Breast. 2022;61:77\u201383. https:\/\/doi.org\/10.1016\/j.breast.2021.12.006.","journal-title":"Breast"},{"issue":"10","key":"2122_CR16","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1093\/jnci\/djq090","volume":"102","author":"BC Yankaskas","year":"2010","unstructured":"Yankaskas BC, Haneuse S, Kapp JM, Kerlikowske K, Geller B, Buist DS, et al. Performance of first mammography examination in women younger than 40 years. J Natl Cancer Inst. 2010;102(10):692\u2013701. https:\/\/doi.org\/10.1093\/jnci\/djq090.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2122_CR17","doi-asserted-by":"publisher","first-page":"168","DOI":"10.7326\/0003-4819-138-3-200302040-00008","volume":"138","author":"PA Carney","year":"2003","unstructured":"Carney PA, Miglioretti DL, Yankaskas BC, Kerlikowske K, Rosenberg R, Rutter CM, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med. 2003;138(3):168\u201375. https:\/\/doi.org\/10.7326\/0003-4819-138-3-200302040-00008.","journal-title":"Ann Intern Med"},{"issue":"5","key":"2122_CR18","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1158\/1078-0432.CCR-11-2599","volume":"18","author":"HA Azim Jr","year":"2012","unstructured":"Azim HA Jr., Michiels S, Bedard PL, Singhal SK, Criscitiello C, Ignatiadis M, et al. Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling. Clin Cancer Res. 2012;18(5):1341\u201351. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-2599.","journal-title":"Clin Cancer Res"},{"key":"2122_CR19","doi-asserted-by":"publisher","first-page":"viii566","DOI":"10.1093\/annonc\/mdy297.015","volume":"29","author":"A Abdelaziz","year":"2018","unstructured":"Abdelaziz A, Abdou A, Habeeb C. Breast cancer treatment waiting time, patient and provider contributions: An Egyptian breast cancer centre experience. Ann Oncol. 2018;29:viii566. https:\/\/doi.org\/10.1093\/annonc\/mdy297.015.","journal-title":"Ann Oncol"},{"issue":"1","key":"2122_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s42506-019-0026-5","volume":"94","author":"AF Manzour","year":"2019","unstructured":"Manzour AF, Gamal Eldin DA. Awareness about breast cancer and mammogram among women attending outpatient clinics, Ain Shams University Hospitals, Egypt. J Egypt Public Health Assoc. 2019;94(1):26. https:\/\/doi.org\/10.1186\/s42506-019-0026-5.","journal-title":"J Egypt Public Health Assoc"},{"issue":"2","key":"2122_CR21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.21608\/jhiph.2018.19918","volume":"48","author":"S Diab","year":"2018","unstructured":"Diab S, Wahdan I, Abdel Gawwad E, Sallam S. Mammography screening utilization behavior among Egyptian female employees in Alexandria. J High Inst Public Health. 2018;48(2):114\u201324.","journal-title":"J High Inst Public Health"},{"issue":"4","key":"2122_CR22","doi-asserted-by":"publisher","first-page":"522","DOI":"10.4103\/ijcm.IJCM_41_20","volume":"45","author":"BMM Salama","year":"2020","unstructured":"Salama BMM. Factors Affecting Mammography Screening Utilization among Educated Women in Al Beheira Governorate, Egypt. Indian J Community Med. 2020;45(4):522\u20135. https:\/\/doi.org\/10.4103\/ijcm.IJCM_41_20.","journal-title":"Indian J Community Med"},{"issue":"10071","key":"2122_CR23","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S0140-6736(16)31392-7","volume":"389","author":"O Ginsburg","year":"2017","unstructured":"Ginsburg O, Bray F, Coleman MP, Vanderpuye V, Eniu A, Kotha SR, et al. The global burden of women\u2019s cancers: a grand challenge in global health. Lancet. 2017;389(10071):847\u201360. https:\/\/doi.org\/10.1016\/S0140-6736(16)31392-7.","journal-title":"Lancet"},{"issue":"1","key":"2122_CR24","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13058-024-01930-6","volume":"26","author":"KA Councell","year":"2024","unstructured":"Councell KA, Polcari AM, Nordgren R, Skolarus TA, Benjamin AJ, Shubeck SP. Social vulnerability is associated with advanced breast cancer presentation and all-cause mortality: a retrospective cohort study. Breast Cancer Res. 2024;26(1):176. https:\/\/doi.org\/10.1186\/s13058-024-01930-6.","journal-title":"Breast Cancer Res"},{"key":"2122_CR25","doi-asserted-by":"publisher","unstructured":"Viswalingam V, Kumar D. Disparities in breast cancer incidence, diagnosis, and outcomes: current status and future directions. Advancements in the Treatment and Prevention of Breast Cancer. 2026:227\u2009\u2013\u200954. https:\/\/doi.org\/10.1016\/B978-0-443-33653-9.00014-4.","DOI":"10.1016\/B978-0-443-33653-9.00014-4"},{"key":"2122_CR26","volume-title":"Country card Egypt: improving breast cancer care in the MEA region","author":"A Manzano","year":"2024","unstructured":"Manzano A, Gral\u00e9n K, Wilking N, Hofmarcher T. Country card Egypt: improving breast cancer care in the MEA region. Lund, Sweden: IHE \u2013 The Swedish Institute for Health Economics; 2024. Report No.: IHE Report 2024:6 Contract No.: 18\/3\/2026."},{"issue":"1","key":"2122_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1080\/13696998.2024.2435750","volume":"28","author":"KA Wahab","year":"2025","unstructured":"Wahab KA, Hassan A, Morsi A, Amritlal S, Meiwald A, Hughes R, et al. The indirect costs of five cancers in Egypt: years of life lost and productivity costs. J Med Econ. 2025;28(1):36\u201343. https:\/\/doi.org\/10.1080\/13696998.2024.2435750.","journal-title":"J Med Econ"},{"issue":"1","key":"2122_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/17938120.2025.2453410","volume":"17","author":"MN Sharkawy","year":"2025","unstructured":"Sharkawy MN, Zaky HS, Selim M, Kassem L. Out of pocket costs and financial hardships among breast cancer patients in Egypt: a pilot study. Middle East Dev J. 2025;17(1):58\u201372. https:\/\/doi.org\/10.1080\/17938120.2025.2453410.","journal-title":"Middle East Dev J"},{"key":"2122_CR29","unstructured":"Egyptian Women\u2019s Health Initiative. \u0627\u0644\u0631\u0626\u0627\u0633\u0629\/\u0645\u0628\u0627\u062f\u0631\u0629 \u0631\u0626\u064a\u0633 \u0627\u0644\u062c\u0645\u0647\u0648\u0631\u064a\u0629 \u0644\u062f\u0639\u0645 \u0635\u062d\u0629 \u0627\u0644\u0645\u0631\u0623\u0629 \u0627\u0644\u0645\u0635\u0631\u064a\u0629 2020 [Available from: https:\/\/www.presidency.eg\/en\/%D8%A7%D9%84%D8%B1%D8%A6%D8%A7%D8%B3%D8%A9\/%D9%85%D8%A8%D8%A7%D8%AF%D8%B1%D8%A9-%D8%B1%D8%A6%D9%8A%D8%B3-%D8%A7%D9%84%D8%AC%D9%85%D9%87%D9%88%D8%B1%D9%8A%D8%A9-%D9%84%D8%AF%D8%B9%D9%85-%D8%B5%D8%AD%D8%A9-%D8%A7%D9%84%D9%85%D8%B1%D8%A3%D8%A9-%D8%A7%D9%84%D9%85%D8%B5%D8%B1%D9%8A%D8%A9\/]."},{"key":"2122_CR30","unstructured":"Egypt State Information Service. Egypt\u2019s women\u2019s health initiative reaches 70\u00a0M women 2025 [Available from: https:\/\/sis.gov.eg\/en\/media-center\/news\/egypts-womens-health-initiative-reaches-70m-women\/ ]."},{"key":"2122_CR31","unstructured":"Women\u2019s Health Initiative. 2024 [Available from: https:\/\/www.100millionseha.eg\/women\/about ]."},{"issue":"9855","key":"2122_CR32","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/S0140-6736(12)61611-0","volume":"380","author":"Independent UKPoBCS","year":"2012","unstructured":"Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet. 2012;380(9855):1778\u201386. https:\/\/doi.org\/10.1016\/S0140-6736(12)61611-0.","journal-title":"Lancet"},{"key":"2122_CR33","volume-title":"WHO position paper on mammography screening","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. WHO position paper on mammography screening. Geneva, Switzerland: World Health Organization; 2014. Contract No.: 18\/3\/2026."},{"key":"2122_CR34","doi-asserted-by":"publisher","first-page":"S929","DOI":"10.1016\/j.annonc.2023.09.3109","volume":"34","author":"HA Azim","year":"2023","unstructured":"Azim HA, Kassem L, Shohdy KS, Safwat Y, Khallaf E, Naguib S, et al. 1759MO Clinical breast examination for early diagnosis of breast cancer: An Egyptian nationwide study. Ann Oncol. 2023;34:S929. https:\/\/doi.org\/10.1016\/j.annonc.2023.09.3109.","journal-title":"Ann Oncol"},{"key":"2122_CR35","volume-title":"Global breast cancer initiative implementation framework: assessing, strengthening and scaling up of services for the early detection and management of breast cancer","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. Global breast cancer initiative implementation framework: assessing, strengthening and scaling up of services for the early detection and management of breast cancer. Switzerland: Geneva; 2023."},{"key":"2122_CR36","doi-asserted-by":"publisher","first-page":"381574","DOI":"10.1155\/2015\/381574","volume":"2015","author":"JA Schlichting","year":"2015","unstructured":"Schlichting JA, Soliman AS, Schairer C, Harford JB, Hablas A, Ramadan M, et al. Breast cancer by age at diagnosis in the Gharbiah, Egypt, population-based registry compared to the United States Surveillance, Epidemiology, and End Results Program, 2004\u20132008. Biomed Res Int. 2015;2015:381574. https:\/\/doi.org\/10.1155\/2015\/381574.","journal-title":"Biomed Res Int"},{"issue":"4","key":"2122_CR37","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2013.12.002","volume":"67","author":"IR Diamond","year":"2014","unstructured":"Diamond IR, Grant RC, Feldman BM, Pencharz PB, Ling SC, Moore AM, et al. Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J Clin Epidemiol. 2014;67(4):401\u20139. https:\/\/doi.org\/10.1016\/j.jclinepi.2013.12.002.","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"2122_CR38","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1111\/j.1525-1497.2006.00609.x","volume":"21","author":"MD Schleinitz","year":"2006","unstructured":"Schleinitz MD, DePalo D, Blume J, Stein M. Can differences in breast cancer utilities explain disparities in breast cancer care? J Gen Intern Med. 2006;21(12):1253\u201360. https:\/\/doi.org\/10.1111\/j.1525-1497.2006.00609.x.","journal-title":"J Gen Intern Med"},{"issue":"5","key":"2122_CR39","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1177\/0272989X08315241","volume":"28","author":"DM Naimark","year":"2008","unstructured":"Naimark DM, Bott M, Krahn M. The half-cycle correction explained: two alternative pedagogical approaches. Med Decis Mak. 2008;28(5):706\u201312. https:\/\/doi.org\/10.1177\/0272989X08315241.","journal-title":"Med Decis Mak"},{"key":"2122_CR40","unstructured":"NHS England. Cancer Survival in England, cancers diagnosed 2016 to 2020, followed up to 2021 2023 [Available from: https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/cancer-survival-in-england\/cancers-diagnosed-2016-to-2020-followed-up-to-2021 ]."},{"key":"2122_CR41","unstructured":"Al-Sisi increases. minimum wage, pensions to EGP 2,000, EGP 900 respectively 2019 [Available from: https:\/\/www.dailynewsegypt.com\/2019\/03\/30\/al-sisi-increases-minimum-wage-pension-to-egp-2000-egp-900-respectively\/ ]."},{"issue":"1","key":"2122_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jval.2021.11.1351","volume":"25","author":"D Husereau","year":"2022","unstructured":"Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, et al. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations. Value Health. 2022;25(1):3\u20139. https:\/\/doi.org\/10.1016\/j.jval.2021.11.1351.","journal-title":"Value Health"},{"key":"2122_CR43","first-page":"464","volume-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"MF Drummond","year":"2015","unstructured":"Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. 4th ed. Oxford, United Kingdom: Oxford University Press; 2015. p. 464.","edition":"4"},{"issue":"Suppl 1","key":"2122_CR44","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1111\/j.1075-122X.2006.00199.x","volume":"12","author":"BO Anderson","year":"2006","unstructured":"Anderson BO, Shyyan R, Eniu A, Smith RA, Yip CH, Bese NS, et al. Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J. 2006;12(Suppl 1):S3\u201315. https:\/\/doi.org\/10.1111\/j.1075-122X.2006.00199.x.","journal-title":"Breast J"},{"key":"2122_CR45","doi-asserted-by":"publisher","first-page":"n256","DOI":"10.1136\/bmj.n256","volume":"372","author":"I Mittra","year":"2021","unstructured":"Mittra I, Mishra GA, Dikshit RP, Gupta S, Kulkarni VY, Shaikh HKA, et al. Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai. BMJ. 2021;372:n256. https:\/\/doi.org\/10.1136\/bmj.n256.","journal-title":"BMJ"},{"issue":"6","key":"2122_CR46","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.jval.2012.06.014","volume":"15","author":"U Siebert","year":"2012","unstructured":"Siebert U, Alagoz O, Bayoumi AM, Jahn B, Owens DK, Cohen DJ, et al. State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force\u20133. Value Health. 2012;15(6):812\u201320. https:\/\/doi.org\/10.1016\/j.jval.2012.06.014.","journal-title":"Value Health"},{"key":"2122_CR47","unstructured":"World Bank. Life expectancy at birth, female (years) \u2013 Egypt, Arab Rep.: World Bank. 2024 [Available from: https:\/\/data.worldbank.org\/indicator\/SP.DYN.LE00.FE.IN?locations=EG]."},{"issue":"2","key":"2122_CR48","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.vhri.2013.06.014","volume":"2","author":"GH Elsisi","year":"2013","unstructured":"Elsisi GH, Kalo Z, Eldessouki R, Elmahdawy MD, Saad A, Ragab S, et al. Recommendations for Reporting Pharmacoeconomic Evaluations in Egypt. Value Health Reg Issues. 2013;2(2):319\u201327. https:\/\/doi.org\/10.1016\/j.vhri.2013.06.014.","journal-title":"Value Health Reg Issues"},{"issue":"4","key":"2122_CR49","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3322\/caac.21393","volume":"67","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Connolly JL, Edge SB, Mittendorf EA, Rugo HS, Solin LJ, et al. Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(4):290\u2013303. https:\/\/doi.org\/10.3322\/caac.21393.","journal-title":"CA Cancer J Clin"},{"key":"2122_CR50","unstructured":"American Cancer Society. Breast Cancer Stages: American Cancer Society. 2026 [Available from: https:\/\/www.cancer.org\/cancer\/types\/breast-cancer\/understanding-a-breast-cancer-diagnosis\/stages-of-breast-cancer.html ]."},{"issue":"3","key":"2122_CR51","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/bjc.2012.596","volume":"108","author":"S Taghipour","year":"2013","unstructured":"Taghipour S, Banjevic D, Miller AB, Montgomery N, Jardine AK, Harvey BJ. Parameter estimates for invasive breast cancer progression in the Canadian National Breast Screening Study. Br J Cancer. 2013;108(3):542\u20138. https:\/\/doi.org\/10.1038\/bjc.2012.596.","journal-title":"Br J Cancer"},{"issue":"7","key":"2122_CR52","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/s41416-022-01904-5","volume":"127","author":"LC Cheung","year":"2022","unstructured":"Cheung LC, Albert PS, Das S, Cook RJ. Multistate models for the natural history of cancer progression. Br J Cancer. 2022;127(7):1279\u201388. https:\/\/doi.org\/10.1038\/s41416-022-01904-5.","journal-title":"Br J Cancer"},{"issue":"6","key":"2122_CR53","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.jval.2012.04.012","volume":"15","author":"DM Eddy","year":"2012","unstructured":"Eddy DM, Hollingworth W, Caro JJ, Tsevat J, McDonald KM, Wong JB, et al. Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force\u20137. Value Health. 2012;15(6):843\u201350. https:\/\/doi.org\/10.1016\/j.jval.2012.04.012.","journal-title":"Value Health"},{"key":"2122_CR54","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-015-0327-2","author":"P Vemer","year":"2016","unstructured":"Vemer P, Corro Ramos I, van Voorn GA, Al MJ, Feenstra TL, AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users. PharmacoEconomics. 2016;34(4):349\u201361. https:\/\/doi.org\/10.1007\/s40273-015-0327-2.\u00a0"},{"key":"2122_CR55","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.vhri.2018.01.006","volume":"16","author":"AN Skrundevskiy","year":"2018","unstructured":"Skrundevskiy AN, Omar OS, Kim J, Soliman AS, Korolchuk TA, Wilson FA. Return on Investment Analysis of Breast Cancer Screening and Downstaging in Egypt: Implications for Developing Countries. Value Health Reg Issues. 2018;16:22\u20137. https:\/\/doi.org\/10.1016\/j.vhri.2018.01.006.","journal-title":"Value Health Reg Issues"},{"key":"2122_CR56","doi-asserted-by":"publisher","first-page":"102894","DOI":"10.1016\/j.eclinm.2024.102894","volume":"77","author":"B Hutchinson","year":"2024","unstructured":"Hutchinson B, Watts R, Nyangasi M, Anderson BO, Chepchumba J, Wangia E, et al. An economic evaluation of breast cancer interventions in Kenya. EClinicalMedicine. 2024;77:102894. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102894.","journal-title":"EClinicalMedicine"},{"issue":"9","key":"2122_CR57","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1007\/s00268-010-0620-3","volume":"34","author":"A Denewer","year":"2010","unstructured":"Denewer A, Hussein O, Farouk O, Elnahas W, Khater A, El-Saed A. Cost-effectiveness of clinical breast assessment-based screening in rural Egypt. World J Surg. 2010;34(9):2204\u201310. https:\/\/doi.org\/10.1007\/s00268-010-0620-3.","journal-title":"World J Surg"},{"issue":"6","key":"2122_CR58","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1080\/13696998.2020.1724682","volume":"23","author":"GH Elsisi","year":"2020","unstructured":"Elsisi GH, Nada Y, Rashad N, Carapinha J, Noor AO, Almasri DM, et al. Cost-effectiveness of six months versus 1-year adjuvant trastuzumab in HER2 positive early breast cancer in Egypt. J Med Econ. 2020;23(6):575\u201380. https:\/\/doi.org\/10.1080\/13696998.2020.1724682.","journal-title":"J Med Econ"},{"issue":"1","key":"2122_CR59","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/13696998.2024.2441073","volume":"28","author":"B Pollinger","year":"2025","unstructured":"Pollinger B, Haiderali A, Huang M, Akyol Ersoy B, Abdelaziz AH, Kassem L, et al. The cost-effectiveness of treatment for high-risk, early-stage, triple-negative breast cancer in Egypt: an analysis of neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant single-agent pembrolizumab. J Med Econ. 2025;28(1):105\u201313. https:\/\/doi.org\/10.1080\/13696998.2024.2441073.","journal-title":"J Med Econ"},{"issue":"8","key":"2122_CR60","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1177\/0269216317690685","volume":"31","author":"S Junger","year":"2017","unstructured":"Junger S, Payne SA, Brine J, Radbruch L, Brearley SG. Guidance on Conducting and REporting DElphi Studies (CREDES) in palliative care: Recommendations based on a methodological systematic review. Palliat Med. 2017;31(8):684\u2013706. https:\/\/doi.org\/10.1177\/0269216317690685.","journal-title":"Palliat Med"},{"key":"2122_CR61","unstructured":"World Bank. Unemployment, female (% of female labor force) (national estimate) Washington, DC: World Bank. 2026 [Available from: https:\/\/data.worldbank.org\/indicator\/SL.UEM.TOTL.FE.NE.ZS ]."},{"issue":"4","key":"2122_CR62","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1524-4733.2008.00489.x","volume":"12","author":"M Drummond","year":"2009","unstructured":"Drummond M, Barbieri M, Cook J, Glick HA, Lis J, Malik F, et al. Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report. Value Health. 2009;12(4):409\u201318. https:\/\/doi.org\/10.1111\/j.1524-4733.2008.00489.x.","journal-title":"Value Health"},{"issue":"4","key":"2122_CR63","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s40273-021-01100-y","volume":"40","author":"S Al Shabasy","year":"2022","unstructured":"Al Shabasy S, Abbassi M, Finch A, Roudijk B, Baines D, Farid S. The EQ-5D-5L Valuation Study in Egypt. PharmacoEconomics. 2022;40(4):433\u201347. https:\/\/doi.org\/10.1007\/s40273-021-01100-y.","journal-title":"PharmacoEconomics"},{"key":"2122_CR64","volume-title":"Annual average official exchange rate, Egyptian pound against the United States dollar, calendar year 2024","author":"Central Bank of Egypt","year":"2025","unstructured":"Central Bank of Egypt. Annual average official exchange rate, Egyptian pound against the United States dollar, calendar year 2024. Egypt: Cairo; 2025."},{"issue":"9","key":"2122_CR65","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.jval.2019.03.021","volume":"22","author":"HC Turner","year":"2019","unstructured":"Turner HC, Lauer JA, Tran BX, Teerawattananon Y, Jit M. Adjusting for Inflation and Currency Changes Within Health Economic Studies. Value Health. 2019;22(9):1026\u201332. https:\/\/doi.org\/10.1016\/j.jval.2019.03.021.","journal-title":"Value Health"},{"key":"2122_CR66","doi-asserted-by":"publisher","unstructured":"Robberstad B. QALYs vs DALYs vs LYs gained: What are the differences, and what difference do they make for health care priority setting? Norsk epidemiologi. 2005;15(2). https:\/\/doi.org\/10.5324\/nje.v15i2.217.","DOI":"10.5324\/nje.v15i2.217"},{"key":"2122_CR67","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/bmb\/ldq033","volume":"96","author":"SJ Whitehead","year":"2010","unstructured":"Whitehead SJ, Ali S. Health outcomes in economic evaluation: the QALY and utilities. Br Med Bull. 2010;96:5\u201321. https:\/\/doi.org\/10.1093\/bmb\/ldq033.","journal-title":"Br Med Bull"},{"issue":"2","key":"2122_CR68","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0167-6296(94)00044-5","volume":"14","author":"MA Koopmanschap","year":"1995","unstructured":"Koopmanschap MA, Rutten FF, van Ineveld BM, van Roijen L. The friction cost method for measuring indirect costs of disease. J Health Econ. 1995;14(2):171\u201389. https:\/\/doi.org\/10.1016\/0167-6296(94)00044-5.","journal-title":"J Health Econ"},{"issue":"7","key":"2122_CR69","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s40273-013-0056-3","volume":"31","author":"M Krol","year":"2013","unstructured":"Krol M, Brouwer W, Rutten F. Productivity costs in economic evaluations: past, present, future. PharmacoEconomics. 2013;31(7):537\u201349. https:\/\/doi.org\/10.1007\/s40273-013-0056-3.","journal-title":"PharmacoEconomics"},{"issue":"6","key":"2122_CR70","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jval.2012.04.014","volume":"15","author":"AH Briggs","year":"2012","unstructured":"Briggs AH, Weinstein MC, Fenwick EA, Karnon J, Sculpher MJ, Paltiel AD, et al. Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force\u20136. Value Health. 2012;15(6):835\u201342. https:\/\/doi.org\/10.1016\/j.jval.2012.04.014.","journal-title":"Value Health"},{"issue":"8","key":"2122_CR71","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/hec.635","volume":"10","author":"E Fenwick","year":"2001","unstructured":"Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ. 2001;10(8):779\u201387. https:\/\/doi.org\/10.1002\/hec.635.","journal-title":"Health Econ"},{"issue":"1","key":"2122_CR72","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s42506-024-00159-7","volume":"99","author":"AN Fasseeh","year":"2024","unstructured":"Fasseeh AN, Korra N, Elezbawy B, Sedrak AS, Gamal M, Eldessouki R, et al. Framework for developing cost-effectiveness analysis threshold: the case of Egypt. J Egypt Public Health Assoc. 2024;99(1):12. https:\/\/doi.org\/10.1186\/s42506-024-00159-7.","journal-title":"J Egypt Public Health Assoc"},{"issue":"3","key":"2122_CR73","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/ijc.33506","volume":"149","author":"H Elghazaly","year":"2021","unstructured":"Elghazaly H, Aref AT, Anderson BO, Arun B, Yip CH, Abdelaziz H, et al. The first BGICC consensus and recommendations for breast cancer awareness, early detection and risk reduction in low- and middle-income countries and the MENA region. Int J Cancer. 2021;149(3):505\u201313. https:\/\/doi.org\/10.1002\/ijc.33506.","journal-title":"Int J Cancer"},{"key":"2122_CR74","unstructured":"World Health Organization. The Global Breast Cancer Initiative. Empowering women, building capacity, providing care for all. Geneva, Switzerland: World Health Organization. 2026 [Available from: https:\/\/www.who.int\/initiatives\/global-breast-cancer-initiative#:~:text=in%20access%20to%20resource,5%20million%20lives]."},{"issue":"17","key":"2122_CR75","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1056\/NEJMoa050518","volume":"353","author":"DA Berry","year":"2005","unstructured":"Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353(17):1784\u201392. https:\/\/doi.org\/10.1056\/NEJMoa050518.","journal-title":"N Engl J Med"},{"issue":"3","key":"2122_CR76","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1148\/radiol.11110469","volume":"260","author":"L Tabar","year":"2011","unstructured":"Tabar L, Vitak B, Chen TH, Yen AM, Cohen A, Tot T, et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology. 2011;260(3):658\u201363. https:\/\/doi.org\/10.1148\/radiol.11110469.","journal-title":"Radiology"},{"issue":"3","key":"2122_CR77","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1158\/1055-9965.EPI-08-0918","volume":"18","author":"CH Ahern","year":"2009","unstructured":"Ahern CH, Shen Y. Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines. Cancer Epidemiol Biomarkers Prev. 2009;18(3):718\u201325. https:\/\/doi.org\/10.1158\/1055-9965.EPI-08-0918.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"13","key":"2122_CR78","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1200\/JCO.2004.05.009","volume":"22","author":"JS Mandelblatt","year":"2004","unstructured":"Mandelblatt JS, Schechter CB, Yabroff KR, Lawrence W, Dignam J, Muennig P, et al. Benefits and costs of interventions to improve breast cancer outcomes in African American women. J Clin Oncol. 2004;22(13):2554\u201366. https:\/\/doi.org\/10.1200\/JCO.2004.05.009.","journal-title":"J Clin Oncol"},{"issue":"4","key":"2122_CR79","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1001\/jama.2015.18392","volume":"315","author":"AL Siu","year":"2016","unstructured":"Siu AL, Force USPST, Bibbins-Domingo K, Grossman DC, Baumann LC, Davidson KW, et al. Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2016;315(4):380\u20137. https:\/\/doi.org\/10.1001\/jama.2015.18392.","journal-title":"JAMA"},{"issue":"3","key":"2122_CR80","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1053\/j.seminoncol.2010.05.006","volume":"37","author":"JM Croswell","year":"2010","unstructured":"Croswell JM, Ransohoff DF, Kramer BS. Principles of cancer screening: lessons from history and study design issues. Semin Oncol. 2010;37(3):202\u201315. https:\/\/doi.org\/10.1053\/j.seminoncol.2010.05.006.","journal-title":"Semin Oncol"},{"issue":"3","key":"2122_CR81","doi-asserted-by":"publisher","first-page":"R41","DOI":"10.1186\/bcr3427","volume":"15","author":"SW Duffy","year":"2013","unstructured":"Duffy SW, Parmar D. Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time. Breast Cancer Res. 2013;15(3):R41. https:\/\/doi.org\/10.1186\/bcr3427.","journal-title":"Breast Cancer Res"}],"container-title":["Archives of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13690-026-02122-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-026-02122-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-026-02122-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:04:53Z","timestamp":1792807493000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13690-026-02122-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2122"],"URL":"https:\/\/doi.org\/10.1186\/s13690-026-02122-8","relation":{"references":[{"id-type":"doi","id":"10.1007\/s40273-015-0327-2","asserted-by":"subject"}]},"ISSN":["2049-3258"],"issn-type":[{"value":"2049-3258","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]},"assertion":[{"value":"16 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present study is an economic evaluation based on secondary, aggregated, and non-identifiable data sources and decision-analytic modeling. The study did not involve recruitment of human participants, collection of primary patient data, access to identifiable personal information, or any direct interaction with patients. Therefore, formal ethics committee approval and informed consent were not required under the applicable Egyptian regulations governing research involving human subjects. As the study did not involve human participants or identifiable human data, the Declaration of Helsinki was not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"228"}}